Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

When should the Oncotype DX assay be used?

April 26, 2017assay DX Oncotype Used

0

Posted

When should the Oncotype DX assay be used?

1 Answer

0

Posted

The Oncotype DX assay can be ordered as soon as resected tumor tissue is available for submission to Genomic Health. The Oncotype DX assay is intended for use in women newly diagnosed with early stage invasive breast cancer who are either stage I/II node-negative, estrogen-receptor-positive or postmenopausal, node-positive, hormone-receptor-positive and provides information that may be used to enhance treatment planning.